BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disorder with unknown cause. Genetic mutations account for a minority of cases but the role of environmental factors is unclear. METHODS: We performed a population-based screening for PD in subjects in an Amish community over age 60. PD was diagnosed using standard clinical criteria and the Unified Parkinson Disease Rating Scale motor subsection 3 (UPDRS3). Community prevalence was calculated. We constructed a community pedigree and calculated kinship coefficients, a measure of relatedness between 2 subjects, for every pair of subjects in diagnostic categories: clinically definite PD, UPDRS3 score >9, Mini-Mental State Exam (MMSE) score <25, and normal. RESULTS: Of 262 eligible subjects, 213 agreed to participate, 15 had PD, 43 had MMSE <25, 73 had UPDRS3 >9. The prevalence of PD was 5,703/100,000 with increasing prevalence in every decade of age. Excluding first-degree relatives, normal subjects were more related to each other (0.0102, SD = 0.0266) than subjects with clinically definite PD (0.0054, SD = 0.0100; p = 0.00003), subjects with UPDRS >9 (0.0076, SD = 0.0155; p = 0.00001), and subjects with MMSE <25 (0.0090, SD = 0.0180; p = 0.00003). CONCLUSIONS: PD and parkinsonian signs are common in this population and the prevalence increases with age. The finding that subjects with PD were not more related than normal subjects suggests that environmental factors may contribute to the parkinsonian phenotype in this community. Copyright 2009 S. Karger AG, Basel.
BACKGROUND:Parkinson's disease (PD) is a neurodegenerative disorder with unknown cause. Genetic mutations account for a minority of cases but the role of environmental factors is unclear. METHODS: We performed a population-based screening for PD in subjects in an Amish community over age 60. PD was diagnosed using standard clinical criteria and the Unified Parkinson Disease Rating Scale motor subsection 3 (UPDRS3). Community prevalence was calculated. We constructed a community pedigree and calculated kinship coefficients, a measure of relatedness between 2 subjects, for every pair of subjects in diagnostic categories: clinically definite PD, UPDRS3 score >9, Mini-Mental State Exam (MMSE) score <25, and normal. RESULTS: Of 262 eligible subjects, 213 agreed to participate, 15 had PD, 43 had MMSE <25, 73 had UPDRS3 >9. The prevalence of PD was 5,703/100,000 with increasing prevalence in every decade of age. Excluding first-degree relatives, normal subjects were more related to each other (0.0102, SD = 0.0266) than subjects with clinically definite PD (0.0054, SD = 0.0100; p = 0.00003), subjects with UPDRS >9 (0.0076, SD = 0.0155; p = 0.00001), and subjects with MMSE <25 (0.0090, SD = 0.0180; p = 0.00003). CONCLUSIONS:PD and parkinsonian signs are common in this population and the prevalence increases with age. The finding that subjects with PD were not more related than normal subjects suggests that environmental factors may contribute to the parkinsonian phenotype in this community. Copyright 2009 S. Karger AG, Basel.
Authors: S Papapetropoulos; J Ellul; C Paschalis; A Athanassiadou; A Papadimitriou; T Papapetropoulos Journal: Eur J Neurol Date: 2003-05 Impact factor: 6.089
Authors: Y Hatano; K Sato; B Elibol; H Yoshino; Y Yamamura; V Bonifati; H Shinotoh; M Asahina; S Kobayashi; A R Ng; R L Rosales; S Hassin-Baer; Y Shinar; C S Lu; H C Chang; Y H Wu-Chou; F B Ataç; T Kobayashi; T Toda; Y Mizuno; N Hattori Journal: Neurology Date: 2004-10-26 Impact factor: 9.910
Authors: Andrew A Hicks; Hjörvar Pétursson; Thorlákur Jónsson; Hreinn Stefánsson; Hrefna S Jóhannsdóttir; Jesus Sainz; Michael L Frigge; Augustine Kong; Jeffrey R Gulcher; Kári Stefánsson; Sigurlaug Sveinbjörnsdóttir Journal: Ann Neurol Date: 2002-11 Impact factor: 10.422
Authors: S Sveinbjörnsdottir; A A Hicks; T Jonsson; H Pétursson; G Guğmundsson; M L Frigge; A Kong; J R Gulcher; K Stefansson Journal: N Engl J Med Date: 2000-12-14 Impact factor: 91.245
Authors: D J Hampshire; E Roberts; Y Crow; J Bond; A Mubaidin; A L Wriekat; A Al-Din; C G Woods Journal: J Med Genet Date: 2001-10 Impact factor: 6.318
Authors: Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink Journal: Science Date: 2002-11-21 Impact factor: 47.728
Authors: Caterina Rosano; David A Bennett; Anne B Newman; Vijay Venkatraman; Kristine Yaffe; Tamara Harris; Stephen Kritchevsky; Howard J Aizenstein Journal: J Gerontol A Biol Sci Med Sci Date: 2012-02-24 Impact factor: 6.053
Authors: Anna C Cummings; Stephen L Lee; Jacob L McCauley; Lan Jiang; Amy Crunk; Lynne L McFarland; Paul J Gallins; Denise Fuzzell; Clare Knebusch; Charles E Jackson; William K Scott; Margaret A Pericak-Vance; Jonathan L Haines Journal: Ann Hum Genet Date: 2011-05 Impact factor: 1.670
Authors: Michael D F Goldenberg; Xuemei Huang; Honglei Chen; Lan Kong; Teodor T Postolache; John W Stiller; Katherine A Ryan; Mary Pavlovich; Toni I Pollin; Alan R Shuldiner; Richard B Mailman; Braxton D Mitchell Journal: Neuroepidemiology Date: 2020-07-31 Impact factor: 3.282
Authors: Woei-Jyh Lee; Toni I Pollin; Jeffrey R O'Connell; Richa Agarwala; Alejandro A Schäffer Journal: BMC Med Genet Date: 2010-05-02 Impact factor: 2.103
Authors: Andrea R Waksmunski; Yeunjoo E Song; Tyler G Kinzy; Reneé A Laux; Jane Sewell; Denise Fuzzell; Sarada Fuzzell; Sherri Miller; Janey L Wiggs; Louis R Pasquale; Jonathan M Skarie; Jonathan L Haines; Jessica N Cooke Bailey Journal: Int J Environ Res Public Health Date: 2021-02-06 Impact factor: 3.390